IPSEN PHARMA

In News

Ipsen backs away from cancer med Tazverik after safety signals emerge in lymphoma trial - Fierce Pharma

Fierce Pharma - Mar 09, 2026

Ipsen takes Tazverik off shelves after malignancy signal in confirmatory trial - FirstWord Pharma

FirstWord Pharma - Mar 09, 2026

Safety concerns prompt Ipsen to pull Tazverik from market - pharmaphorum

pharmaphorum - Mar 09, 2026

Ipsen Voluntarily Withdraws Tazverik Due to Safety Concerns - Oncology Nurse Advisor

Oncology Nurse Advisor - Mar 11, 2026

Pharma Pulse: Ipsen’s Global Tazemetostat Withdrawal and FDA Approval of Deucravacitinib for Psoriatic Arthritis - Pharmaceutical Commerce

Pharmaceutical Commerce - Mar 10, 2026

Ipsen to withdraw cancer drug acquired in buyout due to safety concerns - BioPharma Dive

BioPharma Dive - Mar 09, 2026

Ipsen Pulls Cancer Drug Amid Risk of Secondary Malignancies - BioSpace

BioSpace - Mar 09, 2026

Ipsen removes Tazverik from market and cancels all trials with the blood cancer drug - Managed Healthcare Executive

Managed Healthcare Executive - Mar 10, 2026

Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma - GlobeNewswire

GlobeNewswire - Mar 09, 2026

Ipsen Voluntarily Withdraws Tazemetostat From All Markets Following Safety Signal in Confirmatory Trial - Pharmacy Times

Pharmacy Times - Mar 09, 2026

Therapeutic focus - Ipsen

Ipsen - Oct 15, 2025

Ipsen Withdraws Tazverik from Market Due to Emerging Data from Clinical Trial - Pharmaceutical Executive

Pharmaceutical Executive - Mar 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment